PHARMACOLOGY AND PHARMACOKINETICS OF EZETIMIBE AND SIMVASTATIN FOR DYSLIPIDEMIA

Journal Title: World Journal of Pharmaceutical Research - Year 2019, Vol 8, Issue 11

Abstract

Cardiovascular disease involves cardiovascular systems: heart, blood vessels, and blood circulation system. One of the main risks of cardiovascular disease is arteriosclerosis resulted from dyslipidemia in which LDL cholesterol increases. Simvastatin is one of the derivatives of Statins also known as 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase used to reduce cholesterol. Ezetimibe reduces cholesterol by working in the brush border located in the small intestine to block the reabsorption of cholesterol. As a result, less cholesterol is taken to the liver. The combination of ezetimibe (10mg) and simvastatin (10, 20, 40 mg) is effective in reducing the level of LDL-C, so it can be used to cure dyslipidemia suffered by patients with an increased cardiovascular disease risk.

Authors and Affiliations

Irma Novrianti

Keywords

Related Articles

MATERNAL TRIGLYCERIDES LEVELS AND NEWBORN WEIGHT IN PREGNANT DIABETIC WOMEN

The research aimed to determine the predictive value of serum triglyceride levels (TG) for neonatal weight in pregnant women with positive diabetic screening but normal glucose tolerance. Pre-pregnancy BMI and fasting ma...

A REVIEW ON TREATMENT OF RENAL ANEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HEMODIALYSIS

Anemia is one of the most common and morbid complications of chronic kidney disease, causing unpleasant symptoms and reducing the quality of life. It is a very common complication of CKD and result in the interference of...

FLUORIDE AND ITS INTERACTION WITH HUMAN LIFE - A REVIEW

The objective of this comprehensive review is to update the impact of Sodium Fluoride on human system and other life on the earth. Sodium Fluoride is a source of Fluoride ion used in miscellaneous applications includes h...

A CONTROLLED STUDY OF BODY MASS INDEX IN KENYAN CHILDREN WITH HEARING DISABILITY

Poor nutritional status of children with a hearing disability (HD) is of growing interest, as countries with high levels of malnutrition often report higher rates of disability. The study intended to determine the levels...

EVALUATION OF ANTIHISTAMINE ACTIVITY

Histamine is an important chemical mediator of inflammation, vasodilation, increased vascular permeability, decreased peripheral resistance, airway smooth muscle contraction, and sensory nerve stimulation causing itching...

Download PDF file
  • EP ID EP673249
  • DOI -
  • Views 131
  • Downloads 0

How To Cite

Irma Novrianti (2019). PHARMACOLOGY AND PHARMACOKINETICS OF EZETIMIBE AND SIMVASTATIN FOR DYSLIPIDEMIA. World Journal of Pharmaceutical Research, 8(11), 88-100. https://europub.co.uk/articles/-A-673249